Dendritic cell–specific deletion of PKCδ in offspring of allergic mothers prevents the predisposition for development of allergic lung inflammation in offspring
Journal of Leukocyte Biology · 2024
DOI: 10.1093/jleuko/qiae207 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Leukocyte Biology, 2024. Verfasst von Jacquelyn D Lajiness und 4 weiteren Autor:innen. Beteiligte Einrichtung: Division of Neonatal-Perinatal Medicine, Department of Pediatrics, Indiana University School of Medicine, Indianapolis, IN 46202, United States. Hauptthemen laut MEDLINE: Dendritic Cells, Protein Kinase C-delta, Pneumonia, Hypersensitivity. Die Arbeit nennt 43 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIH HHS, NICHD NIH HHS, NIAID NIH HHS.
Abstract (Originalsprache)
In humans and in mice, maternal allergy predisposes offspring to development of allergy. In murine models, increased levels of maternal β-glucosylceramides are both necessary and sufficient for the development of allergic predisposition in offspring. Furthermore, increased numbers of CD11b+ dendritic cell subsets in the offspring of allergic mothers are associated with allergic predisposition. In vitro, β-glucosylceramides increase CD11b+ dendritic cell subset numbers through increased PKCδ signaling, but it is not known if enhanced PKCδ signaling in dendritic cells is required in vivo. We demonstrate that dendritic cell–specific deletion of PKCδ prevents the β-glucosylceramide–induced increase in CD11b+ dendritic cell subset numbers both in vitro as well as in vivo in the fetal liver of offspring of mothers injected with β-glucosylceramides. Furthermore, dendritic cell–specific deletion of PKCδ in offspring prevents the maternal allergy–induced increase in CD11b+ dendritic cell subsets and decreases allergen-induced interleukin-5 and eosinophilia in lungs of offspring. However, loss of PKCδ in dendritic cells did not prevent development of allergen-specific IgE. Our study provides mechanistic insight into the function of PKCδ in the origins of allergic disease beginning in utero as well as in the development of postnatal allergic lung inflammation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Neonatal-Perinatal Medicine, Department of Pediatrics, Indiana University School of Medicine, Indianapolis, IN 46202, United States.
- Herman B. Wells Center for Pediatric Research, Department of Pediatrics, Indiana University School of Medicine, Indianapolis, IN 46202, United States.
- Department of Microbiology and Immunology, Indiana University School of Medicine, Indianapolis, IN 46202, United States.
ORCID-Profile: Joan M Cook-Mills
Förderung
- NIH HHS
- NICHD NIH HHS
- NIAID NIH HHS
- Eunice Kennedy Shriver National Institute of Child Health and Human Development
- NIDDK NIH HHS
- National Institutes of Health
Zitieren
APA
Lajiness, J. D., Bloodworth, J. C., Blankenship, R. L., Kosins, A. E., & Cook-Mills, J. M. (2024). Dendritic cell–specific deletion of PKCδ in offspring of allergic mothers prevents the predisposition for development of allergic lung inflammation in offspring. Journal of Leukocyte Biology. https://doi.org/10.1093/jleuko/qiae207
Vancouver
Lajiness JD, Bloodworth JC, Blankenship RL, Kosins AE, Cook-Mills JM. Dendritic cell–specific deletion of PKCδ in offspring of allergic mothers prevents the predisposition for development of allergic lung inflammation in offspring. Journal of Leukocyte Biology. 2024. doi:10.1093/jleuko/qiae207
BibTeX
@article{Lajiness2024,
author = {Lajiness, Jacquelyn D and Bloodworth, Jeffrey C and Blankenship, Ross L and Kosins, Allison E and Cook-Mills, Joan M},
title = {Dendritic cell–specific deletion of PKCδ in offspring of allergic mothers prevents the predisposition for development of allergic lung inflammation in offspring},
journal = {Journal of Leukocyte Biology},
year = {2024},
doi = {10.1093/jleuko/qiae207}
}
EUVIMED